Albert P. Parker serves as Executive at OncoCyte Corp, where they oversee executive responsibilities. Since joining the company, Albert P. Parker has executed 12 insider transactions totaling $8.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 10, 2023 involved transacting 33,685 shares valued at $0.
Albert P. Parker currently holds 193,333 shares of OncoCyte Corp (OCX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Albert P. Parker has been a net buyer of OCX stock. They have purchased $6.7K and sold $1.7K worth of shares.
Albert P. Parker's most recent insider trade was on Oct 10, 2023, when they sold 33,685 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 10, 2023 | ZYNE | $0 | Award | 85,000 | $N/A | Discretionary |
| Feb 15, 2023 | ZYNE | $1.7K | Sale | 3,173 | $0.54 | Discretionary |
| Feb 8, 2023 | ZYNE | $3.3K | Payment | 5,463 | $0.60 | Discretionary |
| Feb 7, 2023 | ZYNE | $0 | Award | 18,864 | $N/A | Discretionary |
| Feb 1, 2023 | ZYNE | $3.5K | Payment | 5,841 | $0.60 | Discretionary |
| Jan 31, 2023 | ZYNE | $0 | Award | 17,631 | $N/A | Discretionary |
| Jan 24, 2023 | ZYNE | $0 | Award | 170,000 | $N/A | Discretionary |
| Feb 14, 2022 | ZYNE | $0 | Award | 35,000 | $N/A | Discretionary |
| Dec 11, 2020 | OCX | $0 | Award | 5,586 | $N/A | Discretionary |
| Aug 3, 2020 | OCX | $6.7K | Purchase | 5,000 | $1.33 | Discretionary |